National Institutes of Health· United States · 13d
The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
Conditions apply. Read the eligibility section below before you start.
At a glance
- Where
- United States
- Closes
- Posted
- How to apply
- On their website
Opens on their website. We are not involved in the application.
About this opportunity
<p>This Notice of Funding Opportunity (NOFO) invites new applications to participate in the Diseases of Gastrointestinal Interoception Consortium (DGIC). The overall objectives of this consortium are to: 1) identify the underlying mechanisms that link altered GI interception more directly to GI dysmotility and symptoms; 2) identify disease or response biomarkers that better assess pathophysiology or treatment efficacy; and 3) leverage state-of-the-art technologies to identify novel therapeutic targets that could be assessed in future clinical trials. </p><p>This NOFO uses a cooperative agreement mechanism (U01) and runs in parallel with a companion NOFO (<a href="https://www.grants.gov/search-results-detail/360623">RFA-DK-28-214)</a>. </p>
Who may apply
- No country restriction stated
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Know someone this suits?
Sharing is how most people here hear about an opportunity in time.